EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study

Litao Zhao, Jie Bao, Xiaomeng Qiao, Pengfei Jin, Yanting Ji, Zhenkai Li, Ji Zhang, Yueting Su, Libiao Ji, Junkang Shen, Yueyue Zhang, Lei Niu und 6 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2023-02 · 50 (3) · 727-741

DOI: 10.1007/s00259-022-06036-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 21.11.2022. Verfasst von Litao Zhao und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering Medicine, Beihang University, Beijing, 100191, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Deep Learning. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Nature Science Foundation of Beijing, Gusu health talent project of Suzhou, Special program for diagnosis and treatment Technology of clinical Key diseases in Suzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to develop deep learning (DL) models based on multicentre biparametric magnetic resonance imaging (bpMRI) for the diagnosis of clinically significant prostate cancer (csPCa) and compare the performance of these models with that of the Prostate Imaging and Reporting and Data System (PI-RADS) assessment by expert radiologists based on multiparametric MRI (mpMRI).

Methods

We included 1861 consecutive male patients who underwent radical prostatectomy or biopsy at seven hospitals with mpMRI. These patients were divided into the training (1216 patients in three hospitals) and external validation cohorts (645 patients in four hospitals). PI-RADS assessment was performed by expert radiologists. We developed DL models for the classification between benign and malignant lesions (DL-BM) and that between csPCa and non-csPCa (DL-CS). An integrated model combining PI-RADS and the DL-CS model, abbreviated as PIDL-CS, was developed. The performances of the DL models and PIDL-CS were compared with that of PI-RADS.

Results

In each external validation cohort, the area under the receiver operating characteristic curve (AUC) values of the DL-BM and DL-CS models were not significantly different from that of PI-RADS ( P > 0.05), whereas the AUC of PIDL-CS was superior to that of PI-RADS ( P < 0.05), except for one external validation cohort ( P > 0.05). The specificity of PIDL-CS for the detection of csPCa was much higher than that of PI-RADS ( P < 0.05).

Conclusion

Our proposed DL models can be a potential non-invasive auxiliary tool for predicting csPCa. Furthermore, PIDL-CS greatly increased the specificity of csPCa detection compared with PI-RADS assessment by expert radiologists, greatly reducing unnecessary biopsies and helping radiologists achieve a precise diagnosis of csPCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsDeep LearningHumansMaleMagnetic Resonance ImagingRetrospective StudiesProstate

Stichwörter der Autor:innen

Clinically significant prostate cancerDeep learningMagnetic resonance imagingPI-RADS

Autor:innen und Institutionen

  • School of Engineering Medicine, Beihang University, Beijing, 100191, China.
  • Key Laboratory of Big Data-Based Precision Medicine (Beihang University), Ministry of Industry and Information Technology of China, Beijing, 100191, China.
  • School of Biological Science and Medical Engineering, Beihang University, Beijing, 100191, China.
  • Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China.
  • Department of Radiology, The Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang, 215638, Jiangsu, China.
  • Department of Radiology, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, 215028, Jiangsu, China.

ORCID-Profile: Jie Tian

Förderung

  • the Nature Science Foundation of Beijing
  • Gusu health talent project of Suzhou
  • Special program for diagnosis and treatment Technology of clinical Key diseases in Suzhou
  • National Natural Science Foundation of China
  • Key-Area Research and Development Program of Guangdong Province

Zitieren

APA

Zhao, L., Bao, J., Qiao, X., Jin, P., Ji, Y., Li, Z., Zhang, J., Su, Y., Ji, L., Shen, J., Zhang, Y., Niu, L., Xie, W., Hu, C., Shen, H., Wang, X., Liu, J., & Tian, J. (2023). Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study. European Journal of Nuclear Medicine and Molecular Imaging, 50(3), 727-741. https://doi.org/10.1007/s00259-022-06036-9

Vancouver

Zhao L, Bao J, Qiao X, Jin P, Ji Y, Li Z, et al. Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study. European Journal of Nuclear Medicine and Molecular Imaging. 2023;50(3):727-741. doi:10.1007/s00259-022-06036-9

BibTeX
@article{Zhao2023,
  author = {Zhao, Litao and Bao, Jie and Qiao, Xiaomeng and Jin, Pengfei and Ji, Yanting and Li, Zhenkai and Zhang, Ji and Su, Yueting and Ji, Libiao and Shen, Junkang and Zhang, Yueyue and Niu, Lei and Xie, Wanfang and Hu, Chunhong and Shen, Hailin and Wang, Ximing and Liu, Jiangang and Tian, Jie},
  title = {Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  volume = {50},
  number = {3},
  pages = {727--741},
  doi = {10.1007/s00259-022-06036-9}
}
Kostenlos starten →